NCT01811290View on ClinicalTrials.gov

A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis

UnknownOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2018

Study Completion Date

December 31, 2018

Conditions
Multiple Sclerosis
Trial Locations (1)

98034

MS Center at Evergreen Health, Kirkland

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Simnad, Virginia, M.D.

INDIV

NCT01811290 - A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis | Biotech Hunter | Biotech Hunter